NASDAQ · Medical - Instruments & Supplies

AZTA (AZTA) Stock

$29.88 +6.22% NASDAQ: AZTA Healthcare

Valuation

MetricValue
Price$29.88
Market Cap$1.38B
P/E Ratio-15.22
P/B Ratio0.50
P/S Ratio1.57
EPS (TTM)$0.00
52-Week High$41.73
52-Week Low$19.87
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.24%
ROA-2.72%
ROCE-0.64%
Gross Margin-1.85%
Operating Margin-1.85%
Net Margin-29.86%
Debt/Equity0.04
Current Ratio2.97

Annual Financials (USD)

Metric20212022202320242025
Revenue$514.0M$555.0M$665.0M$573.0M$594.0M
Operating Profit$4.0M$-24.0M$-82.0M$-30.0M$-11.0M
Net Profit$111.0M$-429.0M$-14.0M$-165.0M$-56.0M
EPS$-0.39$-0.15$-0.22$-3.09$-1.22
Op Margin0.7%-4.3%-12.4%-5.2%-1.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.8B$3.7B$2.9B$2.1B$2.1B
Total Liabilities$494.0M$353.0M$351.0M$331.0M$331.0M
Cash$227.0M$658.0M$679.0M$311.0M$280.0M
Borrowings$95.0M$49.0M$60.0M$71.0M$111.0M

Latest News

Azenta Completes Sale of B Medical Systems PR Newswire · Jul 8, 2026 3 Reasons to Avoid AZTA and 1 Stock to Buy Instead StockStory · Jun 19, 2026 3 Cash-Heavy Stocks We Keep Off Our Radar StockStory · Jun 16, 2026 3 Hyped Up Stocks We Find Risky StockStory · Jun 11, 2026 3 Small-Cap Stocks with Open Questions StockStory · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$150.0M$-466.0M$6.0M$50.0M$72.0M
Investing Cash Flow$-199.0M$1.4B$392.0M$187.0M$-124.0M
Financing Cash Flow$0$-10.0M$-844.0M$-662.0M$-11.0M
Net Cash Flow$-17.0M$756.0M$-357.0M$-363.0M$-24.0M
Free Cash Flow$97.0M$-543.0M$-34.0M$12.0M$38.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA13.74
FCF Yield3.08%
Quick Ratio2.52
Interest Coverage—
Return 1Y-17.92%
Return 3Y-39.63%
Return 5Y-70.63%

Ownership

Insiders Held1.00%
Institutions Held116.86%
Institutions Float Held118.04%
Institutional HolderSharesReport Date
Blackrock Inc.6,724,9892026-03-31
Politan Capital Management LP4,622,4502026-03-31
Conestoga Capital Advisors, LLC2,844,5462026-03-31
Vanguard Portfolio Management LLC2,450,4922026-03-31
Dimensional Fund Advisors LP2,060,3222026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BLFS $32.15 +2.78% -96.00 $1.57B 0.00%
ESTA $92.80 +0.28% -38.58 $2.73B 0.00%
EVOEvotec SE $2.01 -6.07% -3.26 $713.93M 0.00%
KMTS $23.99 +5.08% -3.85 $1.41B 0.00%
NEOG $9.29 +1.09% -1.69 $2.02B 0.00%

About AZTA

AZTA is led by CEO John Marotta, publicly traded since 1995.

AZTA stock trades at $29.88 with a market capitalization of $1.38B. The stock is valued at a price-to-earnings (P/E) ratio of -15.22, price-to-book of 0.50, price-to-sales of 1.57. Over the past 52 weeks the stock has ranged between $19.87 and $41.73, and currently trades 28.4% below its 52-week high.

On profitability, AZTA generates a return on equity (ROE) of -3.24%, return on capital employed of -0.64%, an operating margin of -1.85%, a net profit margin of -29.86%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides